Studies on disease-modifying antirheumatic drugs: Synthesis of novel quinoline and quinazoline derivatives and their anti-inflammatory effect
Baba A, Kawamura N, Makino H, Ohta Y, Taketomi S, Sohda T (1996) Studies on disease-modifying antirheumatic drugs: synthesis of novel quinoline and quinazoline derivatives and their anti-inflammatory effect. J Med Chem 39:5176-5182
Structure-activity relationship study of antimalarial indolo [2,1-b]quinazoline-6,12-diones (tryptanthrins). Three dimensional pharmacophore modeling and identification of new antimalarial candidates
Bhattacharjee AK, Hartell MG, Nichols DA, Hicks RP, Stanton B, van Hamont JE, Milhous WA (2004) Structure-activity relationship study of antimalarial indolo [2,1-b]quinazoline-6,12-diones (tryptanthrins). Three dimensional pharmacophore modeling and identification of new antimalarial candidates. Eur J Med Chem 39:59-67
Effects of a new 1,3,4-thiadiazolium mesoionic compound, MI-D, on the acute inflammatory response
Cardoso JC, Cadena SMSC, Zampronio A, Arruda AMS, Carnieri EGS, Echevarria A, Constantin J, Bracht A, Oliveira MBM (2004) Effects of a new 1,3,4-thiadiazolium mesoionic compound, MI-D, on the acute inflammatory response. Drug Dev Res 61:207-217
Potential antileprotic agents. 3. Inhibition of mycobacterial dihydrofolic reductase by 2,4-diamino-5-methyl-6-alkylquinazolines
DeGraw JI, Brown GH, Colwell WT (1974) Potential antileprotic agents. 3. Inhibition of mycobacterial dihydrofolic reductase by 2,4-diamino-5-methyl-6- alkylquinazolines. J Med Chem 17: 762-764
Niementowski reaction: Microwave induced and conventional synthesis of quinazolinones and 3-methyl-1H-5-pyrazolones and their antimicrobial activity
Desai AR, Desai KR (2005) Niementowski reaction: microwave induced and conventional synthesis of quinazolinones and 3-methyl-1H-5-pyrazolones and their antimicrobial activity. Arkivoc 13:98-108
Biological evaluation of novel 6-arylbenzimidazo [1,2-c]quinazoline derivatives as inhibitors of LPS-induced TNF-alpha secretion
Galarce GD, Foncea RE, Edwards AM, Pessoa-mahana H, Pessoamahana CD, Ebensperger RA (2008) Biological evaluation of novel 6-arylbenzimidazo [1,2-c]quinazoline derivatives as inhibitors of LPS-induced TNF-alpha secretion. Biol Res 41:43-50
Transition metal complexes of a potential anticancer quinazoline ligand
Gudasi KB, Patil SA, Kulkarni MV, Nethaji M (2009) Transition metal complexes of a potential anticancer quinazoline ligand. Trans Met Chem 34(3):325-330
Anticonvulsant and sedative-hypnotic activity of some novel 3-[5-(4-substituted) phenyl-1,3,4-oxadiazole-2yl] -2-styrylquinazoline-4(3H)- ones
Kashaw SK, Gupta V, Kashaw V, Mishra P, Stables JP, Jain NK (2010) Anticonvulsant and sedative-hypnotic activity of some novel 3-[5-(4-substituted) phenyl-1,3,4-oxadiazole-2yl]-2-styrylquinazoline-4(3H)-ones. Med Chem Res 19:250-261
Synthesis leading to novel 2,4,6-trisubstituted quinazoline derivatives, their antibacterial and cytotoxic activity against THP-1, HL-60 and A375 cell lines
Mani Chandrika P, Yakaiah T, Narsaiah B, Sridhar B, Venugopal G, Venkateshwara Rao J, Pranay Kumar K, Murthy USN, Raghu Ram Rao A (2009) Synthesis leading to novel 2,4,6-trisubstituted quinazoline derivatives, their antibacterial and cytotoxic activity against THP-1, HL-60 and A375 cell lines. Indian J Chem B 48:840-847